Canada · Delayed Price · Currency is CAD BriaCell Therapeutics Statistics
Total Valuation
TSX:BCT has a market cap or net worth of CAD 33.06 million. The enterprise value is 1.13 million.
| Market Cap | 33.06M |
| Enterprise Value | 1.13M |
Important Dates
The next estimated earnings date is Tuesday, October 27, 2026.
| Earnings Date | Oct 27, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
TSX:BCT has 8.70 million shares outstanding. The number of shares has increased by 1,260.31% in one year.
| Current Share Class | 8.70M |
| Shares Outstanding | 8.70M |
| Shares Change (YoY) | +1,260.31% |
| Shares Change (QoQ) | +158.73% |
| Owned by Insiders (%) | 2.10% |
| Owned by Institutions (%) | 6.33% |
| Float | 7.86M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 1.04 |
| P/TBV Ratio | 1.02 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 7.07
| Current Ratio | 7.07 |
| Quick Ratio | 6.35 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -1,080.95 |
Financial Efficiency
Return on equity (ROE) is -175.25% and return on invested capital (ROIC) is -113.26%.
| Return on Equity (ROE) | -175.25% |
| Return on Assets (ROA) | -90.84% |
| Return on Invested Capital (ROIC) | -113.26% |
| Return on Capital Employed (ROCE) | -136.41% |
| Weighted Average Cost of Capital (WACC) | 13.28% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -2.61M |
| Employee Count | 16 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -90.69% in the last 52 weeks. The beta is 1.64, so TSX:BCT's price volatility has been higher than the market average.
| Beta (5Y) | 1.64 |
| 52-Week Price Change | -90.69% |
| 50-Day Moving Average | 5.23 |
| 200-Day Moving Average | 9.40 |
| Relative Strength Index (RSI) | 33.84 |
| Average Volume (20 Days) | 10,845 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -43.60M |
| Pretax Income | -42.17M |
| Net Income | -41.76M |
| EBITDA | -43.45M |
| EBIT | -43.60M |
| Earnings Per Share (EPS) | -13.15 |
Balance Sheet
The company has 31.04 million in cash and n/a in debt, with a net cash position of 31.04 million or 3.57 per share.
| Cash & Cash Equivalents | 31.04M |
| Total Debt | n/a |
| Net Cash | 31.04M |
| Net Cash Per Share | 3.57 |
| Equity (Book Value) | 31.86M |
| Book Value Per Share | 4.52 |
| Working Capital | 29.68M |
Cash Flow
In the last 12 months, operating cash flow was -41.96 million and capital expenditures -172,942, giving a free cash flow of -42.13 million.
| Operating Cash Flow | -41.96M |
| Capital Expenditures | -172,942 |
| Depreciation & Amortization | 157,980 |
| Net Borrowing | n/a |
| Free Cash Flow | -42.13M |
| FCF Per Share | -4.84 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
TSX:BCT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1,260.31% |
| Shareholder Yield | -1,260.31% |
| Earnings Yield | -126.31% |
| FCF Yield | -127.45% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on August 25, 2025. It was a reverse split with a ratio of 0.1.
| Last Split Date | Aug 25, 2025 |
| Split Type | Reverse |
| Split Ratio | 0.1 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |